Bayer G4A partners with Seattle startups Litesprite and Prevencio on digital health efforts Two Seattle-area startups were hand-picked by Bayer for a competitive program to create novel digital health solutions. It’s an endorsement… Read More
Study: Seattle-area startup’s test diagnoses heart disease more effectively than current methods Prevencio, a Kirkland, Wash., based biotech startup, today announced the results of the first study on its HART test, which… Read More
Prevencio announces successful study of predictive blood tests for coronary heart disease Prevencio, a Kirkland, Wash., based biotech startup, announced today a successful study on its suite of blood diagnostic tests. The… Read More
